EM Systems Co Ltd (JP:4820)
:4820
Top Page
EM Systems Co
(4820)
Select Model
Select Model
Rating:69Neutral
Price Target:
¥770.00
▲(9.53% Upside)
Action:N/ADate:02/20/26
The score is driven primarily by strong financial quality (especially a conservative balance sheet and solid profitability) and supportive shareholder return via a high dividend yield. These positives are offset by weak technicals (price below key moving averages with negative MACD and oversold momentum) and the key fundamental risk of uneven cash-flow consistency, including a significant 2025 pullback versus 2024.
Positive Factors
Conservative balance sheet
EM Systems' very low leverage and sizable equity base provide durable financial flexibility. A conservative balance sheet supports capex, product investment, and resilience to cyclical pressure, reducing refinancing risk and enabling strategic moves without stressing cash flow over the next several quarters.
Negative Factors
Cash-flow volatility
Operating and free cash flow swung materially between 2024 and 2025, undermining predictability of internal financing. This volatility constrains long-term planning, raises the importance of liquidity buffers, and can limit steady shareholder returns or reinvestment if weak years recur.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
EM Systems' very low leverage and sizable equity base provide durable financial flexibility. A conservative balance sheet supports capex, product investment, and resilience to cyclical pressure, reducing refinancing risk and enabling strategic moves without stressing cash flow over the next several quarters.
Read all positive factors
EM Systems Co (4820) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥45.55B
Dividend Yield5.28%
Average Volume (3M)50.37K
Price to Earnings (P/E)22.4
Beta (1Y)0.54
Revenue GrowthN/A
EPS GrowthN/A
CountryJP
Employees827
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.72
Shares Outstanding70,514,800
10 Day Avg. Volume52,900
30 Day Avg. Volume50,366
Financial Highlights & Ratios
PEG Ratio8.60
Price to Book (P/B)2.69
Price to Sales (P/S)2.32
P/FCF Ratio51.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)28.9
Revenue Forecast (FY)¥22.00B
EM Systems Co Business Overview & Revenue Model
Company Description
EM Systems Co., Ltd. develops and sells various IT systems for pharmacies, clinics, and care/welfares in Japan. It also develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; I...
How the Company Makes Money
null...
EM Systems Co Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.00B | 23.66B | 24.84B | 20.36B | 16.92B | 14.44B |
| Gross Profit | 13.82B | 11.47B | 13.17B | 9.62B | 8.11B | 6.93B |
| EBITDA | 6.70B | 4.97B | 6.03B | 3.79B | 3.37B | 2.85B |
| Net Income | 3.04B | 2.45B | 2.43B | 1.96B | 1.89B | 1.83B |
Balance Sheet | ||||||
| Total Assets | 28.99B | 27.51B | 31.67B | 29.39B | 26.39B | 24.85B |
| Cash, Cash Equivalents and Short-Term Investments | 10.68B | 7.85B | 11.88B | 9.44B | 8.88B | 8.29B |
| Total Debt | 985.00M | 584.00M | 1.44B | 2.57B | 109.00M | 5.00M |
| Total Liabilities | 8.49B | 7.07B | 11.04B | 8.82B | 6.89B | 6.02B |
| Stockholders Equity | 20.46B | 20.39B | 20.59B | 20.52B | 19.48B | 18.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.07B | 5.36B | 1.41B | 2.41B | 1.60B |
| Operating Cash Flow | 0.00 | 2.01B | 5.76B | 1.58B | 2.47B | 1.71B |
| Investing Cash Flow | 0.00 | -2.22B | 194.00M | -2.04B | -577.00M | -499.00M |
| Financing Cash Flow | 0.00 | -3.84B | -3.57B | 993.00M | -1.32B | -738.00M |
EM Systems Co Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥1.12T | 18.91 | 12.15% | 1.01% | 33.50% | 17.26% | |
69 Neutral | ¥45.55B | 22.41 | 15.71% | 5.28% | ― | ― | |
63 Neutral | ¥65.67B | 228.03 | ― | 0.39% | 6.17% | -8918.66% | |
63 Neutral | ¥233.94B | 26.76 | ― | 0.43% | 20.55% | 48.62% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥69.14B | 77.03 | 5.76% | ― | 31.95% | -40.95% | |
44 Neutral | ¥2.79B | -4.28 | ― | ― | 16.19% | -4.42% |
* Healthcare Sector Average
JP:4820
EM Systems Co
678.00
-12.90
-1.87%
JP:2413
M3
1,645.00
17.80
1.09%
JP:4480
Medley
2,112.00
-1,138.00
-35.02%
JP:3902
Medical Data Vision Co.Ltd.
1,684.00
1,282.00
318.91%
JP:4438
Welby Inc.
337.00
44.00
15.02%
JP:4483
JMDC Inc.
3,575.00
642.27
21.90%
EM Systems Co Corporate Events
EM Systems Posts Lower Sales but Maintains Solid Financial Base in FY2025
Feb 13, 2026
EM Systems Co., Ltd. reported a 4.7% decline in net sales to ¥23.66 billion for the year ended December 2025, with operating profit down 17.6% and ordinary profit down 16.8%, though profit attributable to owners of the parent edged up 1.1% to...
EM Systems Revamps Board and Audit Structure Ahead of March 2026 Meeting
Feb 13, 2026
EM Systems announced planned changes to its board of directors and corporate auditors, to take effect following the 43rd Ordinary General Meeting of Shareholders on March 27, 2026. The company named candidates for director roles, including represe...
EM Systems Co. Reports FY2025 Results and Sets Outlook for 2026
Feb 13, 2026
EM Systems Co. has released its results of operations for the financial year ended December 31, 2025, outlining a performance overview, segment status, and progress under its mid-term management plan. The company also presented an earnings forecas...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.